EFM
RNAM

E Fund Management’s Avidity Biosciences RNAM Stock Holding History

E Fund Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$402K Buy
14,163
+629
+5% +$18.7K 0.02% 256
2025
Q1 		$400K Buy
13,534
+955
+8% +$29.7K 0.02% 250
2024
Q4 		$366K Sell
12,579
-212
-2% -$8.86K 0.02% 275
2024
Q3 		$587K Buy
12,791
+6,151
+93% +$267K 0.03% 183
2024
Q2 		$271K Sell
6,640
-2,857
-30% -$82K 0.02% 247
2024
Q1 		$242K Sell
9,497
-979
-9% -$15.3K 0.02% 308
2023
Q4 		$94.8K Sell
10,476
-6,489
-38% -$43.4K 0.01% 303
2023
Q3 		$108K Sell
16,965
-12,499
-42% -$108K 0.01% 282
2023
Q2 		$327K Buy
29,464
+11,943
+68% +$150K 0.03% 208
2023
Q1 		$269K Buy
17,521
+5,075
+41% +$112K 0.02% 249
2022
Q4 		$276K Buy
+12,446
New +$186K 0.02% 243

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

E Fund Management's RNAM Position: Q2 2025 in Review

E Fund Management increased its Avidity Biosciences (RNAM) stake by 4.6% in Q2 2025, buying an estimated $18.7K and bringing the position to 14,163 shares worth $402K. The position accounts for 0.02% of the portfolio, ranked #256.

E Fund Management first reported a position in RNAM in Q4 2022 and has held it in 11 quarters since. The position peaked at $587K in Q3 2024. 206 funds tracked by Wall St. Rank hold RNAM as of Q2 2025.

  • E Fund Management held 14,163 shares of Avidity Biosciences worth $402K as of Q2 2025.
  • E Fund Management bought 629 Avidity Biosciences shares in Q2 2025, an estimated $18.7K.
  • Avidity Biosciences made up 0.02% of E Fund Management's portfolio in Q2 2025, its #256 holding.
  • E Fund Management first reported a position in Avidity Biosciences in Q4 2022 and has held it in 11 quarters since.
  • E Fund Management's Avidity Biosciences position peaked at $587K in Q3 2024.
  • 206 funds tracked by Wall St. Rank held Avidity Biosciences as of Q2 2025.

Based on E Fund Management's 13F filing for Q2 2025, filed 15 Aug 2025.